Cannabis users drove nearly half of psychedelic hotline distress calls, study finds

A study published in Science Advances found that nearly half of the 25,419 calls to the Fireside Project’s Psychedelic Support Line between 2021 and 2026 came from cannabis users experiencing psychological distress. The findings highlight a gap in harm reduction frameworks for the most widely legalized psychoactive substance in the U.S.

Tarun Mottlia

Editor, Lazyfounder

Published Nov 1, 20263 min read

Cannabis users drove nearly half of psychedelic hotline distress calls, study finds — Image: j shot via Flicker, public domain via source

KEY HIGHLIGHTS

Fireside Project’s Psychedelic Support Line received 25,419 calls between April 2021 and February 2026, nearly half from cannabis users experiencing psychological distress.
47% of cannabis users called in a state of panic or concern about their marijuana use, while 70% sought help during active use.
Cannabis is the most widely legalized psychoactive substance in the U.S. but remains excluded from harm reduction frameworks.
The study, published in Science Advances, involved researchers from Paris and Geneva and analyzed 2,004 cannabis-related distress calls.

Cannabis calls dominated distress hotline data

Between April 2021 and February 2026, the Fireside Project’s Psychedelic Support Line received 25,419 calls, according to a study published in Science Advances. Nearly half of those seeking help were cannabis users, not individuals using psychedelics like psilocybin or LSD as the hotline originally intended to serve.

The study, conducted in collaboration with researchers from Paris and Geneva, found that 47% of cannabis users called while experiencing panic or concern about their marijuana use. Of these, 70% reached out during active cannabis use, while only 25% sought integration support for past experiences.

Cannabis’ exclusion from harm reduction frameworks

Despite being the most widely legalized psychoactive substance in the U.S., cannabis remains largely excluded from harm reduction programs and mental health crisis infrastructure. The study’s authors noted that while psychedelics like psilocybin and MDMA are central to public health debates, the psychological risks of cannabis receive far less attention.

The data shows this oversight translates to real-world consequences: 2,004 cannabis-related distress calls were logged over five years, indicating a recurring pattern of psychological distress. By comparison, MDMA users were more likely to call for integration support (66%) rather than active distress.

Policy and market implications

Fireside Project’s founder, Joshua White, emphasized that the hotline’s data could help policymakers develop evidence-based guidelines for harm reduction. The study provides epidemiological evidence of the kinds of support callers actually need, which may pressure regulators to expand frameworks beyond traditional psychedelics.

The findings also point to a broader trend in cannabis legalization. As potent strains and novelty products proliferate, the U.S. has seen an uptick in unusual medical episodes—yet support systems have not kept pace. For founders, this signals an opportunity to create cannabis-specific mental health tools or crisis services tailored to this underserved group.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

This study exposes a gap in harm reduction infrastructure for cannabis users, who are often overlooked in public health discussions about psychoactive substances. While psychedelics like psilocybin and MDMA dominate policy debates, cannabis—despite its widespread legalization and use—lacks dedicated support systems for psychological distress. For founders and operators in mental health, addiction services, or public health tech, this signals an underserved market: tools or services tailored to cannabis-related distress could address a real and recurring need.

The findings also challenge assumptions about who seeks crisis support. Cannabis users, not just those using psychedelics, are actively reaching out for help, yet existing frameworks fail to account for their experiences. This data could pressure policymakers to expand harm reduction programs beyond traditional psychedelics, creating opportunities for startups to bridge the gap. If legalization continues without parallel support systems, demand for cannabis-specific mental health resources will likely grow.

Key takeaways

Cannabis-related psychological distress is a recurring phenomenon, with 2,004 distress calls logged over five years—yet harm reduction frameworks largely ignore it.
The mismatch between cannabis’ legal status and its exclusion from mental health crisis infrastructure highlights an opportunity for startups to address an unmet need.
Public health policy may shift as epidemiological data like this study’s forces regulators to reckon with cannabis’ psychological risks, not just its legalization.
Founders in mental health tech or crisis support should consider cannabis-specific solutions, as existing psychedelic-focused services are already fielding demand from this group.

More health news

Sources

Gizmodo · 2026-10-30
The Callers Most Likely to Phone a Psychedelic Hotline Mid-Trip Weren’t on Psychedelics

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author